Has Mohamad Soud, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,500 in general payments to Mohamad Soud, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mohamad Soud, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mohamad Soud, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mohamad Soud, MD

Interventional Cardiology · New Brunswick, NJNPI 1003278292

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.6%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 41.3% of the total. Reporting peaked in 2022 at $4,503 and has fallen 87.3% since, to $572 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NJ, where the typical reported total is $8,550.

$7,500in general payments, 2019–2025

Across 82 payments — averaging $91.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$3K
Boston Scientific$3K
Cardiva Medical, Inc.$435
Inari Medical, Inc.$249
Abiomed$97
Shockwave Medical, Inc$90
plus $559 from 15 others

What the payments were for

Grants$1,00013%
Travel & lodging$2,53034%
Food & beverage$3,79451%
Education$1762%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	31	$3,098
Boston Scientific	16	$2,971
Cardiva Medical, Inc.	5	$435
Inari Medical, Inc.	2	$249
Abiomed	3	$97
Shockwave Medical, Inc	1	$90
Chiesi USA, Inc.	1	$79
Irhythm Technologies, Inc.	2	$70
Amgen	3	$57
Abbott	2	$48
E.r. Squibb & Sons, L.L.C.	3	$48
Heartflow, Inc.	2	$48
Boehringer Ingelheim	2	$37
AstraZeneca	2	$31
Lantheus Medical Imaging, Inc.	1	$28
Novartis	1	$23
Lilly USA, LLC	1	$21
Terumo Medical Corporation	1	$20
Regeneron Healthcare Solutions, Inc.	1	$19
Biotronik Inc.	1	$17
Cardiovascular Systems Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,500 in reported general payments places this provider in the 40th percentile of 166 interventional cardiology providers in New Jersey.

See all interventional cardiology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$76,490

Medicare patients

192

Services billed

596

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	82	$1,102
Rosuvastatin Calcium	28	$759
Carvedilol	33	$536
Metoprolol Succinate	31	$382
Ezetimibe	17	$270
ClopidogrelClopidogrel Bisulfate	16	$256
Valsartan	11	$233
Amlodipine Besylate	17	$190
Furosemide	18	$124
Spironolactone	13	$53

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in New Brunswick

Ankitkumar PatelGlen Ridge$408K
Ziad AbbudOcean$360K
Ramin HastingsHasbrouck Heights$295K
Michael LimHackensack$215K
Darshan GodkarCedar Knolls$194K
Ryan KapleHackensack$178K
Matthew SayboltEatontown$175K
Daniel KissEatontown$172K
Kintur SanghviBordentown$139K
Dimitrios KarmpaliotisMorristown$129K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →